Requirement of MrpH for Mannose-ResistantProteus-Like Fimbria-Mediated Hemagglutination byProteus mirabilis

ABSTRACT Two new genes, mrpH and mrpJ, were identified downstream of mrpG in the mrp gene cluster encoding mannose-resistant Proteus-like (MR/P) fimbriae of uropathogenic Proteus mirabilis. Since the predicted MrpH has 30% amino acid sequence identity to PapG, the Galα(1-4)Gal-binding adhesin of Escherichia coli P fimbriae, we hypothesized that mrpH encodes the functional MR/P hemagglutinin. MR/P fimbriae, expressed in E. coliDH5α, conferred on bacteria both the ability to cause mannose-resistant hemagglutination and the ability to aggregate to form pellicles on the broth surface. Both a ΔmrpH mutant expressed in E. coli DH5α and an isogenicmrpH::aphA mutant of P. mirabilis were unable to produce normal MR/P fimbriae efficiently, suggesting that MrpH was involved in fimbrial assembly. Amino acid residue substitution of the N-terminal cysteine residues (C66S and C128S) of MrpH abolished the receptor-binding activity (hemagglutinating ability) of MrpH but allowed normal fimbrial assembly, supporting the notion that MrpH was the functional MR/P hemagglutinin. Immunogold electron microscopy of P. mirabilis HI4320 revealed that MrpH was located at the tip of MR/P fimbriae, also consistent with its role in receptor binding. The isogenic mrpH::aphA mutant of HI4320 was less able to colonize the urine, bladder, and kidneys in a mouse model of ascending urinary tract infection (P < 0.01), and therefore MR/P fimbriae contribute significantly to bacterial colonization in mice. While there are similarities betweenP. mirabilis MR/P and E. coli P fimbriae, there are more notable differences: (i) synthesis of the MrpH adhesin is required to initiate fimbrial assembly, (ii) MR/P fimbriae confer an aggregation phenotype, (iii) site-directed mutation of specific residues can abolish receptor binding but allows fimbrial assembly, and (iv) mutation of the adhesin gene abolishes virulence in a mouse model of ascending urinary tract infection.

[1]  H. Mobley,et al.  MrpB Functions as the Terminator for Assembly of Proteus mirabilis Mannose-Resistant Proteus-Like Fimbriae , 1998, Infection and Immunity.

[2]  S. Langermann,et al.  Prevention of mucosal Escherichia coli infection by FimH-adhesin-based systemic vaccination. , 1997, Science.

[3]  H. Mobley,et al.  Proteus mirabilis mannose-resistant, Proteus-like fimbriae: MrpG is located at the fimbrial tip and is required for fimbrial assembly , 1997, Infection and immunity.

[4]  I. Blomfield,et al.  In vivo phase variation of MR/P fimbrial gene expression in Proteus mirabilis infecting the urinary tract , 1997, Molecular microbiology.

[5]  S. Moseley,et al.  Mutational analysis of receptor binding mediated by the Dr family of Escherichia coli adhesins , 1997, Molecular microbiology.

[6]  R. Belas,et al.  Swarming and pathogenicity of Proteus mirabilis in the urinary tract. , 1995, Trends in microbiology.

[7]  H. Mobley,et al.  Virulence determinants of uropathogenic Escherichia coli and Proteus mirabilis. , 1994, Kidney international. Supplement.

[8]  R. Russell,et al.  Construction of an MR/P fimbrial mutant of Proteus mirabilis: role in virulence in a mouse model of ascending urinary tract infection , 1994, Infection and immunity.

[9]  R Vanholder,et al.  Inhibition of nuclear uptake of calcitriol receptor by uremic ultrafiltrate. , 1994, Kidney international.

[10]  H. Mobley,et al.  Proteus mirabilis MR/P fimbrial operon: genetic organization, nucleotide sequence, and conditions for expression , 1994, Journal of bacteriology.

[11]  T. Bergfors,et al.  Structural basis of pilus subunit recognition by the PapD chaperone. , 1993, Science.

[12]  Per Falk,et al.  Pilus and nonpilus bacterial adhesins: Assembly and function in cell recognition , 1993, Cell.

[13]  F. Jacob-Dubuisson,et al.  Adhesin presentation in bacteria requires molecular chaperones and ushers , 1992, Infection and immunity.

[14]  S. Hultgren,et al.  Immunoglobulin-like PapD chaperone caps and uncaps interactive surfaces of nascently translocated pilus subunits. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[15]  J. Kaper,et al.  Construction of an eae deletion mutant of enteropathogenic Escherichia coli by using a positive-selection suicide vector , 1991, Infection and immunity.

[16]  R. Belas,et al.  Transposon mutagenesis in Proteus mirabilis , 1991, Journal of bacteriology.

[17]  H. Mobley,et al.  Proteus mirabilis flagella and MR/P fimbriae: isolation, purification, N-terminal analysis, and serum antibody response following experimental urinary tract infection , 1991, Infection and immunity.

[18]  M. Sekiguchi,et al.  Identification and nucleotide sequence of the gene determining the adhesion capacity of Serratia marcescens , 1991, Journal of bacteriology.

[19]  S. Hultgren,et al.  Chaperone-assisted assembly and molecular architecture of adhesive pili. , 1991, Annual review of microbiology.

[20]  H. Mobley,et al.  Hemagglutinin, urease, and hemolysin production by Proteus mirabilis from clinical sources. , 1990, The Journal of infectious diseases.

[21]  S. Ho,et al.  Site-directed mutagenesis by overlap extension using the polymerase chain reaction. , 1989, Gene.

[22]  H. Mobley,et al.  Urease-positive bacteriuria and obstruction of long-term urinary catheters , 1987, Journal of clinical microbiology.

[23]  S. Normark,et al.  Localization of the receptor-binding protein adhesin at the tip of the bacterial pilus , 1987, Nature.

[24]  W. Faulk,et al.  Communication to the editors: An immunocolloid method for the electron microscope , 1971 .

[25]  W. Faulk,et al.  An immunocolloid method for the electron microscope. , 1971, Immunochemistry.